Healthtech Startups

Amylyx is a biopharmaceutical company developing novel therapies for diseases with high unmet medical needs. It focuses on solving difficult medical challenges for affected patients and their families.

4 investors

Angiex develops Nuclear-Delivered Antibody-Drug Conjugate (ND-ADC) therapies for solid cancers, using a platform that delivers chemotherapeutic payloads to the nucleus of tumor cells and tumor blood vessel endothelial cells. Its lead asset, AGX101, is a TM4SF1-directed ADC in Phase 1 clinical development for advanced solid tumors.

4 investors

Anima is a healthcare platform that combines online consultation with productivity tools, featuring EHR integration, advanced analytics, and AI-powered document processing to streamline primary care workflows and improve patient outcomes.

4 investors

Antidote Health provides virtual primary care through board-certified physicians who deliver telehealth services covering preventive care, chronic disease management, urgent care, and specialized support including women's health and pediatric care.

4 investors

Apella provides real-time operating room monitoring and predictive analytics through computer vision and AI integration with EHR systems, helping surgical teams detect delays, optimize scheduling, and improve OR efficiency. The platform serves healthcare providers and surgical operations by automating event documentation and enabling data-driven decisions across the perioperative team.

4 investors

Apian operates a physical AI logistics platform that uses autonomous drones and ground robots to move healthcare resources such as blood, pathology samples, and prescriptions between clinical sites. It orchestrates third-party drone providers to deliver for healthcare systems, including the UK's NHS, with a focus on Europe.

4 investors

Apollomics is a biotechnology company focused on discovering and developing oncology therapies designed to combine with other treatments, using approaches that engage the immune system and target specific molecular pathways to inhibit cancer. It operates as a publicly traded (Nasdaq-listed) drug developer with clinical programs including vebreltinib (APL-101).

4 investors

Applied Cognition develops neuroscience-based therapeutics and diagnostics, leveraging AI and deep expertise in drug development and clinical research for neurological disorders. The company combines scientific discovery with translational research and commercialization capabilities.

4 investors

Aprexis offers a platform for medication therapy management (MTM) and customizable clinical programs covering lifestyle medicine and disease management, using AI-driven patient stratification, a patient-facing mobile app, and EHR interoperability. It serves pharmacists, health plans, and Medicaid/Medicare programs, with tools addressing medication adherence, health equity, and quality metrics such as HEDIS and Stars.

4 investors

Aptimmune develops vaccines for swine health, partnering with vaccine development and swine health consulting companies to speed product development, testing and manufacturing. It serves the swine veterinary and animal health industry.

4 investors

Aqtual is a precision medicine company led by experienced healthcare professionals, entrepreneurs, and technical experts.

4 investors

ArcaScience provides AI-powered benefit-risk intelligence for pharmaceutical drug development, replacing manual literature reviews and CRO services to support decision-making from candidate selection through post-marketing surveillance. The platform serves pharmaceutical teams and regulatory bodies with compliance-ready analyses.

4 investors

AreCor develops proprietary pharmaceutical products for diabetes, obesity, and cardiometabolic diseases using its Arestat technology platform. The company targets areas of high unmet patient need in high-value therapeutic markets.

4 investors

Arini is an AI-powered front desk system for dental groups, DSOs, and private practices that handles patient calls and text messages 24/7, offering scheduling, call routing, and custom workflow management. The platform integrates with existing practice management software and phone systems to book appointments and reduce missed calls.

4 investors

ARS Pharmaceuticals is a biopharmaceutical company developing treatments for severe allergic reactions, with a focus on patient-friendly, easy-to-use intranasal therapies. It serves patients with allergies and their caregivers.

4 investors

ARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue. The company covers the design, manufacture, and distribution of its therapies and builds on radiation research from the University of Oslo and Norway's Radium Hospital.

4 investors

Artisight builds an AI platform that uses computer vision and operational intelligence to improve hospital workflows and clinician efficiency. The platform connects to existing hospital systems and cameras to help healthcare organizations optimize operational performance, quality metrics, and workforce sustainability.

4 investors

Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals. Its Swiss portfolio includes the antiepileptic medication Ontozry (cenobamate).

4 investors

Asgard Therapeutics develops direct cell reprogramming technologies that convert cancer cells into dendritic cells to restore anti-cancer immune responses. The company focuses on oncology immunotherapy through its TrojanDC approach.

4 investors

Aspect provides personalized health management for women by combining data from wearables, glucose monitors, at-home medical tests, and doctor assessments with AI analysis and coaching from healthcare professionals. The platform focuses on chronic condition management with particular attention to women's health issues including PCOS, endometriosis, and menopause.

4 investors

Aspero Medical develops the Pillar balloon overtube solution with micro-textured design to improve control and anchoring during balloon endoscopy for small bowel diagnosis and treatment. The technology reduces procedure time and sedation requirements for gastrointestinal interventions.

4 investors

AssistIQ uses AI-powered computer vision to automatically capture and recognize implants, tissue, and surgical supplies as they are used in the operating room, updating inventory and charge data without manual entry. It serves hospitals and health systems in the United States, integrating with EHR and ERP systems to improve billing accuracy, reduce waste, and support clinical documentation.

4 investors

Aster provides patient management software and agentic AI voice tools for healthcare providers. The company was acquired by Elation.

4 investors

Astrivax Therapeutics is a clinical-stage biopharmaceutical company developing immunotherapies to treat virus-driven cancers, particularly HPV16-associated cancers like cervical and head and neck cancer. The company's Launch-iT platform generates durable T-cell responses against virus-infected cells and is advancing toward clinical proof-of-concept.

4 investors